PUBLISHER: The Business Research Company | PRODUCT CODE: 1945394
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945394
Intermittent pneumatic compression (IPC) devices are inflatable sleeves designed to prevent blood clots by applying external pressure to the legs through compressed air and a pump. These devices consist of cuffs that periodically inflate and deflate, facilitating blood flow by compressing and releasing the affected area. IPC is commonly used to enhance limb circulation, prevent deep vein thrombosis (DVT), and manage conditions such as lymphedema.
The main types of intermittent pneumatic compression (IPC) devices are designed for addressing issues related to deep vein thrombosis (DVT) and pulmonary embolism (PE). Deep vein thrombosis (DVT) is a medical condition characterized by the development of blood clots within deep veins, most commonly found in the legs. These devices are available through various distribution channels, including clinics, pharmacies, online channels, and other offline channels, and cater to different applications, including both home use and hospital use.
Tariffs are impacting the intermittent pneumatic compression devices market by increasing costs of imported pumps, control electronics, sensors, tubing systems, and medical-grade materials required for device assembly. Hospitals and home care providers in North America and Europe are most affected due to reliance on imported components, while Asia-Pacific experiences higher export-related manufacturing costs. These tariffs are increasing device procurement expenses and influencing purchasing decisions. However, they are also encouraging localized production, regional component sourcing, and innovation in cost-effective and portable IPC device solutions.
The intermittent pneumatic compression (ipc) devices market research report is one of a series of new reports from The Business Research Company that provides intermittent pneumatic compression (ipc) devices market statistics, including intermittent pneumatic compression (ipc) devices industry global market size, regional shares, competitors with a intermittent pneumatic compression (ipc) devices market share, detailed intermittent pneumatic compression (ipc) devices market segments, market trends and opportunities, and any further data you may need to thrive in the intermittent pneumatic compression (ipc) devices industry. This intermittent pneumatic compression (ipc) devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The intermittent pneumatic compression (ipc) devices market size has grown strongly in recent years. It will grow from $1.57 billion in 2025 to $1.7 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing incidence of deep vein thrombosis, rising use of preventive compression therapy in hospitals, expansion of post-surgical care protocols, improvements in pneumatic compression design, growing clinical awareness of ipc benefits.
The intermittent pneumatic compression (ipc) devices market size is expected to see strong growth in the next few years. It will grow to $2.29 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing demand for home-use thrombosis prevention devices, rising adoption of connected medical compression systems, expansion of outpatient and home-based care models, growing focus on preventive vascular healthcare, increasing technological advancements in compression therapy. Major trends in the forecast period include increasing adoption of portable ipc devices, rising use of ipc for home-based dvt prevention, growing integration of smart pressure control systems, expansion of sequential compression technologies, enhanced focus on patient compliance and safety.
The increasing number of patients with spinal cord injuries is expected to drive the growth of the intermittent pneumatic compression (IPC) devices market in the coming years. A spinal cord injury involves damage to the spinal cord that leads to loss of function, often resulting in varying levels of paralysis and sensory loss below the site of injury. The growing adoption of robotic exoskeletons for spinal cord injury patients is fueled by their ability to enhance mobility by enabling powered limb movement and upright walking during rehabilitation. Intermittent pneumatic compression (IPC) devices are used in the management of spinal cord injuries to reduce the risk of deep vein thrombosis (DVT) by enhancing blood circulation through sequential compression of the lower limbs. For example, in May 2023, according to the Spinal Cord Injury Statistical Center, a US-based organization, approximately 18,000 new spinal cord injury cases were recorded in the United States in 2023, an increase from around 17,900 cases in 2022. Therefore, the rising number of patients with spinal cord injuries is contributing to the growth of the intermittent pneumatic compression (IPC) devices market.
Major companies operating in the intermittent pneumatic compression (IPC) devices market are emphasizing technological advancements, such as intelligent vascular refill-responsive compression systems, which enhance blood flow and reduce venous stasis by adjusting compression cycles according to each patient's real-time vascular refill patterns. Intelligent vascular refill-responsive compression systems employ sensor-based algorithms to measure refill time and tailor intermittent compression delivery, thereby improving therapeutic effectiveness, boosting circulation, and strengthening venous thromboembolism (VTE) prevention outcomes. For example, in November 2024, Cardinal Health, a US-based healthcare and medical products company, introduced the Kendall SCD SmartFlow Compression System, the newest generation in its Kendall product line. The system incorporates Vascular Refill Detection (VRD) technology along with a sequential, gradient, circumferential sleeve design to move more blood per hour than uniform compression, offering clinicians a more efficient, dependable, and user-friendly solution for preventing VTE and managing pain and swelling associated with venous stasis.
In December 2024, SHS Capital, a Germany-based private equity firm focused on investing in innovative healthcare companies, acquired a majority stake in Medizintechnik Rostock GmbH for an undisclosed amount. Through this acquisition, SHS Capital seeks to support MTR's succession planning while reinforcing its core medical technology operations and facilitating nationwide expansion to improve patient access to homecare therapies across Germany. Medizintechnik Rostock GmbH is a Germany-based medical technology and homecare solutions provider that offers home sequential compression devices as part of its compression therapy services
Major companies operating in the intermittent pneumatic compression (ipc) devices market are Cardinal Health Inc., Medtronic PLC, Medline Industries LP, B. Braun Melsungen AG, Getinge AB, Arjo AB, Tactile Systems Technology Inc., Encompass Group LLC, Currie Medical Specialties Inc., ManaMed Inc., Bio Compression Systems Inc., Direct Healthcare Group Ltd., Devon Medical Inc., Mego Afek A.C. Ltd., BSN medical GmbH, Compression Therapy UK Limited, Air Relax Inc., Innova Medical Group Inc., Huntleigh Healthcare Ltd., Smiths Medical International Ltd.
North America was the largest region in the intermittent pneumatic compression (IPC) devices market in 2025. The regions covered in the intermittent pneumatic compression (ipc) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the intermittent pneumatic compression (ipc) devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The intermittent pneumatic compression (IPC) devices market consists of sales of sequential compression devices, gradient compression devices, lymphedema pumps, custom-fit intermittent pneumatic compression (IPC) devices, air compression sleeves, and boots. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Intermittent Pneumatic Compression (IPC) Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses intermittent pneumatic compression (ipc) devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for intermittent pneumatic compression (ipc) devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intermittent pneumatic compression (ipc) devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.